等待开盘 12-20 09:30:00 美东时间
+3.840
+1.72%
Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
今天 04:17
AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.
12-18 23:14
AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.
11-28 23:50
Healthcare ETFs are raking in fresh inflows while tech bleeds, reflecting a defensive shift as investors grow wary of frothy valuations.
11-26 22:25
A key trading signal flashed for AbbVie shares at a price of $228.47, after which ABBV rose as much as 2.4% to an intraday high of $233.90.
11-13 04:06
https://www.statnews.com/2025/11/12/abbvie-calico-layoffs/?utm_campaign=twitter_organic&utm_source=twitter&utm_medium=social
11-13 00:03
Investors with a lot of money to spend have taken a bullish stance on AbbVie (N...
11-04 01:02
Companies Reporting Before The Bell • T. Rowe Price Group (NASDAQ:TROW) is esti...
10-31 19:11
AbbVie (NYSE:ABBV) is preparing to release its quarterly earnings on Friday, 20...
10-30 22:02
艾伯维公司(AbbVie)周一宣布,其卵巢癌治疗药物艾拉希(Elahere)将在英国上市,标价与美国市场一致。 今年 7 月,美国前总统唐纳德・特朗普曾向 17 家制药企业致函,明确要求这些企业降低药品价格,使其与海外市场售价持平,艾伯维便是其中之一。 该公司于周一表示,目前正与英国成本效益监管机构 —— 国家卫生与临床优化研究所(National Institute for Health and Care Excellence,简称 NICE)展开磋商,以确保该药物获得合理的价值认可。 艾拉希(Elahere)属于一类名为 “抗体药物偶联物”(antibody-drug co...
09-29 22:02